Ten Bay Bio is a biotechnology company that offers biological therapies for treatment of complex diseases in immunology.
Ten Bay Bio has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Ten Bay Bio's investors include Sante Ventures, Clarevia Ventures.
Ten Bay Bio is headquartered in Milwaukee, United States.
Ten Bay Bio is a biotechnology company that offers biological therapies for treatment of complex diseases in immunology.
Ten Bay Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ten Bay Bio — Funding & Investors." VCBacked, June 4, 2025, https://www.vcbacked.co/company/ten-bay-bio. Accessed September 30, 2026.
VCBacked. (2025). Ten Bay Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/ten-bay-bio
{{cite web |title=Ten Bay Bio — Funding & Investors |url=https://www.vcbacked.co/company/ten-bay-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated